Immune responses in patients with esophageal cancer treated with SART1 peptide-pulsed dendritic cell vaccine
/in Dendritic Cells, Esophageal Carcinoma, International Publications /von 2015-01-23 / Int. J. Oncol. 2015 Apr;46(4):1699-709Clinical outcomes of a novel therapeutic vaccine with Tax peptide-pulsed dendritic cells for adult T cell leukaemia/lymphoma in a pilot study
/in Acute Leukemia, Chronic Leukemia, Dendritic Cells, International Publications, Malignant Lymphoma /von 2015-01-22 / Br. J. Haematol. 2015 May;169(3):356-67Immune Suppression during Oncolytic Virotherapy for High-Grade Glioma; Yes or No?
/in Glioblastoma, International Publications, IOZK Veröffentlichungen, Newcastle Disease Virus /von 2015-01-15 / J Cancer 2015;6(3):203-17Immunotherapy for castration-resistant prostate cancer: Progress and new paradigms
/in Dendritic Cells, International Publications, Prostate Cancer /von 2015-01-07 / Urol. Oncol. 2015 May;33(5):245-60Potential approaches for more successful dendritic cell-based immunotherapy
/in Dendritic Cells, International Publications /von 2015-01-02 / Expert Opin Biol Ther 2015 Apr;15(4):569-82EXPLORING THE ANTITUMOR EFFECT OF VIRUS IN MALIGNANT GLIOMA
/in Glioblastoma, International Publications, Newcastle Disease Virus /von 2015-01-01 / Drugs Future 2015;40(11):739-749Prognostic markers for patient outcome following vaccination with multiple MHC Class I/II-restricted WT1 peptide-pulsed dendritic cells plus chemotherapy for pancreatic cancer
/in Dendritic Cells, International Publications, Pancreatic Cancer /von 2015-01-01 / Anticancer Res. 2015 Jan;35(1):555-62Immunotherapy for malignant gliomas
/in Dendritic Cells, Glioblastoma, International Publications /von 2015-01-01 / Cancer Treat. Res. 2015;163:143-58
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de